LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
4.460
-0.180 (-3.88%)
At close: Nov 20, 2026, 4:00 PM EST
4.490
+0.030 (0.67%)
After-hours: Nov 20, 2026, 4:10 PM EST
LENSAR Revenue
LENSAR had revenue of $14.13M in the quarter ending September 30, 2026, a decrease of -1.29%. This brings the company's total for the last twelve months to $60.08M, up 1.59% year-over-year. In the year 2025, LENSAR had annual revenue of $58.44M with 9.24% growth. That makes LENSAR the 26,653rd largest company in the world by revenue and 3,639th in the United States.
Revenue (ttm)
$60.08M
Revenue Growth
+1.59%
P/S Ratio
0.91
Revenue / Employee
$400,527
Employees
150
Market Cap
54.83M
Revenue by Geography
- United States 34.31M 66.4%
- Europe 8.43M 16.3%
- Asia (Excluding South Korea) 8.02M 15.5%
- South Korea 658.00K 1.3%
- Other 238.00K 0.5%
Fiscal year ended Dec 31, 2025 See the full LENSAR breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 58.44M | 4.94M | 9.24% |
| Dec 31, 2024 | 53.49M | 11.33M | 26.87% |
| Dec 31, 2023 | 42.16M | 6.81M | 19.25% |
| Dec 31, 2022 | 35.36M | 899.00K | 2.61% |
| Dec 31, 2021 | 34.46M | 8.08M | 30.62% |
| Dec 31, 2020 | 26.38M | -4.15M | -13.58% |
| Dec 31, 2019 | 30.53M | 6.14M | 25.18% |
| Dec 31, 2018 | 24.39M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Outset Medical | 121.97M |
| electroCore | 37.97M |
| Rapid Micro Biosystems | 36.87M |
| Nyxoah | 32.77M |
| Hyperfine | 19.06M |
| Sensus Healthcare | 16.62M |
| Spectral AI | 14.46M |
| Lucid Diagnostics | 5.44M |
LNSR News
- 11 days ago - Lensar reports Q3 EPS (38c), consensus (14c) - TheFly
- 12 days ago - LENSAR Earnings Call Transcript: Q3 2026 - Transcripts
- 12 days ago - LENSAR Earnings release: Q3 2026 - Filings
- 12 days ago - LENSAR Quarterly report: Q3 2026 - Filings
- 12 days ago - LENSAR® Reports Third Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 19 days ago - LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026 - GlobeNewsWire
- 7 weeks ago - Lensar initiated with a Buy at Lucid Capital - TheFly
- 3 months ago - Lensar price target raised to $10 from $9 at BTIG - TheFly